
    
      A Multicenter, Randomized, Double-Blind, Comparator-Controlled, Placebo-Controlled Study to
      Assess the Efficacy and Safety of Oral CL-H1T in the Treatment of Acute Migraine Pain, With
      or Without Aura, and the Prevention of Migraine-Associated Nausea and Vomiting (MANV)
    
  